Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Action Needed On Competition And Shortages
JAMA Study Of FDA Data Calls For More ANDA Approvals
Oct 17 2019
•
By
Akriti Seth
JAMA calls for increased action from the FDA to tackle shortages and limited competition • Source: Shutterstock
More from Regulation
More from Policy & Regulation